Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332327417> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- W2332327417 endingPage "02" @default.
- W2332327417 startingPage "CN07" @default.
- W2332327417 abstract "The growth of many tumors has been suggested to depend on a subset of tumor cells with an extensive capacity for self-renewal, termed cancer stem cells or tumor-initiating cells (TICs). These cells are not necessarily abundant or proliferative, but because they are long-lived and often resistant to conventional therapies, they are thought to contribute to tumor resistance and recurrence. Therefore, identifying these cells and finding approaches to targeting them has become an important goal in cancer research. We recently identified a population of TICs in a mouse model of medulloblastoma, the most common malignant brain tumor in children. These cells, marked by expression of the cell surface antigen CD15, are capable of propagating tumors following transplantation, whereas CD15– cells from the same donors cannot. To gain insight into the molecular mechanisms underlying the increased tumorigenic potential of CD15+ cells, we compared their gene expression profile to that of CD15– cells. Among the genes most consistently elevated in CD15+ cells were regulators of the G2/M phases of the cell cycle. This observation led us to hypothesize that CD15+ cells display altered cell cycle regulation, and that these cells might be particularly vulnerable to inhibitors of cell cycle progression. Here we show that CD15+ cells move more quickly through the G1 and S phases of the cell cycle, and as a result contain an increased proportion of cells in G2/M. Consistent with this cell cycle skewing, CD15+ cells express higher levels of the G2/M regulators Aurora Kinase (Aurk) and Polo-like Kinase (Plk). Treatment of tumor cells with small molecule antagonists of Aurk or Plk inhibits cell cycle progression, promotes apoptosis and enhances sensitivity to other modes of chemotherapy. Treatment of tumor-bearing mice with these agents also significantly inhibits tumor progression. Importantly, cells from medulloblastoma patient-derived xenografts are also sensitive to Aurk and Plk inhibitors. These findings suggest that inhibitors of Aurk and Plk may be useful for targeting TICs and may represent a novel avenue for therapy of human medulloblastoma. Citation Format: Shirley Markant, Lourdes Adriana Esparza, Kelly Barton, Jesse Sun, Robert Wechsler-Reya,. Targeting tumor-initiating cells in medulloblastoma. [abstract]. In: Proceedings of the Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2012 Oct 16-19; Anaheim, CA. Philadelphia (PA): AACR; Cancer Prev Res 2012;5(11 Suppl):Abstract nr CN07-02." @default.
- W2332327417 created "2016-06-24" @default.
- W2332327417 creator A5023360543 @default.
- W2332327417 creator A5038665722 @default.
- W2332327417 creator A5066651467 @default.
- W2332327417 creator A5072850973 @default.
- W2332327417 creator A5073698295 @default.
- W2332327417 date "2012-11-01" @default.
- W2332327417 modified "2023-09-26" @default.
- W2332327417 title "Abstract CN07-02: Targeting tumor-initiating cells in medulloblastoma" @default.
- W2332327417 doi "https://doi.org/10.1158/1940-6207.prev-12-cn07-02" @default.
- W2332327417 hasPublicationYear "2012" @default.
- W2332327417 type Work @default.
- W2332327417 sameAs 2332327417 @default.
- W2332327417 citedByCount "0" @default.
- W2332327417 crossrefType "journal-article" @default.
- W2332327417 hasAuthorship W2332327417A5023360543 @default.
- W2332327417 hasAuthorship W2332327417A5038665722 @default.
- W2332327417 hasAuthorship W2332327417A5066651467 @default.
- W2332327417 hasAuthorship W2332327417A5072850973 @default.
- W2332327417 hasAuthorship W2332327417A5073698295 @default.
- W2332327417 hasConcept C2780789225 @default.
- W2332327417 hasConcept C502942594 @default.
- W2332327417 hasConcept C71924100 @default.
- W2332327417 hasConceptScore W2332327417C2780789225 @default.
- W2332327417 hasConceptScore W2332327417C502942594 @default.
- W2332327417 hasConceptScore W2332327417C71924100 @default.
- W2332327417 hasIssue "11 Supplement" @default.
- W2332327417 hasLocation W23323274171 @default.
- W2332327417 hasOpenAccess W2332327417 @default.
- W2332327417 hasPrimaryLocation W23323274171 @default.
- W2332327417 hasRelatedWork W1482784375 @default.
- W2332327417 hasRelatedWork W2080856530 @default.
- W2332327417 hasRelatedWork W2100335940 @default.
- W2332327417 hasRelatedWork W2139249750 @default.
- W2332327417 hasRelatedWork W3127318075 @default.
- W2332327417 hasRelatedWork W3178053030 @default.
- W2332327417 hasRelatedWork W3200827662 @default.
- W2332327417 hasRelatedWork W3217802174 @default.
- W2332327417 hasRelatedWork W4248161021 @default.
- W2332327417 hasRelatedWork W4323042187 @default.
- W2332327417 hasVolume "5" @default.
- W2332327417 isParatext "false" @default.
- W2332327417 isRetracted "false" @default.
- W2332327417 magId "2332327417" @default.
- W2332327417 workType "article" @default.